About: rare diseases

Special ReportOpinionPromoted content
Health 24-07-2020

Europe at the crossroad of Rare Diseases innovation: lessons from the past and future outlooks

In shaping the future of rare diseases policies all stakeholders should cooperate to create an environment that actively supports research and clinical development of orphan medicinal products (OMPs). This entails building synergies all across the innovation ecosystem to address the...
Health 23-07-2020

Early stakeholder dialogues crucial for success of rare orphan medicines

Early dialogue between stakeholders is crucial for the effective development and success of rare orphan drugs, used to treat patients with rare diseases, Anna Bucsics, project adviser at the mechanism of coordinated access to orphan medicinal products (MoCA), told EURACTIV in an interview.
Health 13-07-2020

Data sharing critical to close ‘innovation blackhole’ for rare diseases

Access to data and 'real world evidence' obtained from observational data is needed to help push research and innovation on rare diseases, with support needed to encourage and harmonise this across Europe, stakeholders have said. 
Health 13-07-2020

Rare diseases: Ensuring Europe remains at the forefront of innovation

Download PDF  

In the past two decades, a combination of scientific breakthroughs coupled with strong incentive systems has seen considerable progress for rare disease patients, but this innovation has tapered off in recent years.
Special ReportOpinionPromoted content
Health 13-07-2020

The complexity of R&D for orphan medicines

There are multiple challenges inherent to drug development for rare diseases, all consequences of the small number of patients. For most of these diseases, the body of pre-existing knowledge is extremely limited with a lack of crucial information such as...
Special ReportOpinionPromoted content
Health 10-07-2020

From pandemic to rare disease, medical innovation is the answer

Living through a global pandemic, we can take some comfort from the enormous collaborative research and development response that is taking place to find a way out from under the shadow of the COVID-19 crisis. Scientists around the world are...
Health 09-07-2020

MEP: A common EU tool to incentivise production and availability of orphan drugs

When it comes to rare diseases and 'orphan drugs', technology is there to support an “objective” EU tool that could provide the pharma industry with the necessary incentives to research and produce orphan drugs and simultaneously avoid exhausting ailing health systems, MEP Stelios Kympouropoulos told EURACTIV in an interview.
Health 08-07-2020

EU orphan drugs law and the emergence of SMEs

The legal framework provided by the current EU orphan drugs regulation has encouraged a number of small and medium sized companies (SMEs) to develop innovative technologies in the fight against rare diseases in Europe, stakeholders told EURACTIV.com.
Health 07-07-2020

EURORDIS: Rare diseases need more centralised processes within the EU

Future improvement of the EU Orphan Medicines Regulation (OMP) could involve more centralised processes for all rare diseases at the EU level, the European Organisation for Rare Diseases  (EURORDIS) told EURACTIV in a written interview.
Health 06-07-2020

Commission’s ‘risky’ move to re-visit orphan drugs regulation

The European Commission is expected to present by the end of July an evaluation study on the pros and cons of the application of orphan and paediatric regulations, which deal with a niche segment of rare diseases that affect fewer than five in 10,000 people.
Coronavirus 05-05-2020

COVID-19 pandemic hinders access to care for patients with rare diseases

Nine out of ten people living with rare diseases across Europe have been negatively impacted by the coronavirus pandemic, including three out of ten who said that this has caused “life-threatening” disruption, according to a recent study by EURORDIS-Rare Diseases Europe.
 VideoPromoted content
Health 28-02-2020

Rare diseases Day at the European Parliament

People living with SMA, ALS and other rare disease was the focus of the Rare Disease event at the EU Parliament on 18 February. The event was organised by Biogen in collaboration with EURORDIS, the patient organisation for rare diseases.
Health 04-12-2018

Romanian health minister: Prevention and innovative drugs to kill cancer

In order to face the rising cancer incidence across Europe, governments should prioritise prevention policies, as well as access to innovative medicines under an EU-wide plan, Romanian Health Minister Sorina Pintea told EURACTIV.com in an interview.
Health 02-03-2018

EU and UK patients with rare diseases in Brexit limbo

It is still unclear whether the UK will participate after Brexit in the European Reference Networks, which aim to help patients with rare diseases, potentially putting at risk millions of patients.
Health 12-10-2017

Patients: ‘Think carefully’ before questioning orphan drugs’ incentives

Organisations of patients with rare diseases have warned EU policymakers to “think carefully” before reviewing the incentives in the orphan drugs regulation, claiming that the pharma industry should not be discouraged from investing in new therapies.
Health 07-04-2017

IMI chief: ‘We need to learn how to share data in a safe and ethical manner’

Ethicists, humanists, lawyers and patients should come together to understand the risk of data in healthcare and whether patients are willing to take that risk, Pierre Meulien told EURACTIV.com.
Health 01-03-2017

Commission launches reference networks to face rare and complex diseases

In an effort to combat rare diseases and improve patient accessibility, the European Commission launched the European Reference Networks (ERNs) yesterday (28 February).
Health 13-02-2017

Commission must bring healthcare to the fore

Given that the current European Commission has not prioritised healthcare, it looks as though it is up to the European Parliament to push the agenda, writes Denis Horgan.
Health 13-02-2017

Health matters should supersede European bureaucracy

European red tape should not be an obstacle to effective healthcare. For patients with diseases like sarcoma, waiting means suffering and often avoidable death, writes Marlene Mizzi.
Health 10-02-2017

How Italy and France take on rare sarcoma cancers

EU member states are exploring ways to effectively tackle the rising occurrence and complex nature of rare cancers known as sarcomas.
Health 09-02-2017

Complex sarcoma cancer needs an overall strategy, report says

The diverse nature of rare cancers like sarcomas poses severe challenges to the medical community and policy-makers who need to seek a holistic approach, according to a report.
Health 08-02-2017

Andriukaitis: ‘Rare cancers present a particular challenge’

The European Commission’s priority when tackling rare cancers such as sarcomas is to ensure European Reference Networks (ERNS) are put in place so that all patients have access to the best expertise available in the EU, Vytenis Andriukaitis told Euractiv.com in an interview.
Health 07-02-2017

Rare cancers: A headache for policymakers

The complexity of diagnosing and treating rare forms of cancers like sarcomas can be addressed by a multi-level approach and better coordination among member states, insist experts in the field.
 InfographicPromoted content
Rare Diseases in the EU
Health 29-02-2016

INFOGRAPHIC: Rare diseases in the EU

Rare diseases affect more than 30 million Europeans, many of whom are children! What is the European Union doing about it?
Contribute